NLC Health Ventures launches new venture revolutionizing Rheumatoid Arthritis care
NLC Health Ventures introduces Rheumasense, its newest venture poised to transform rheumatoid arthritis (RA) management through real-time, machine-learning-powered biomarker diagnostics. In collaboration with Mayo Clinic, Rheumasense leverages an innovative technology to empower clinicians with precise and timely insights, enabling personalized care for RA patients. Rheumatoid arthritis affects over 18 million people globally and is a […]